Business grows as regulators scrutinise research companies

New York -- Research became something of a dirty word in 2003. Indeed, in early December, the National Association of Securities Dealers (NASD) announced it had censured and fined four more firms -- notably Banc of America Securities and Axiom Capital Management -- for issuing misleading statements and research.

The regulators’ activity on this issue has spurred a number of business developments. One example is the Global Research Analyst Settlement, set up in April between the US Securities and Exchange Commission and 10 brokers. According to the terms of the settlement, which was approved in October, each affected company is required to contract for five years with at least three independent research firms and make those research reports available to their customers. Payment for independent research

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here